Literature DB >> 10082559

p70 S6 kinase is regulated by protein kinase Czeta and participates in a phosphoinositide 3-kinase-regulated signalling complex.

A Romanelli1, K A Martin, A Toker, J Blenis.   

Abstract

p70 S6 kinase (p70S6K) is an important regulator of cell proliferation. Its activation by growth factor requires phosphorylation by various inputs on multiple sites. Data accumulated thus far support a model whereby p70S6K activation requires sequential phosphorylations at proline-directed residues in the putative autoinhibitory pseudosubstrate domain, as well as threonine 389. Threonine 229, a site in the catalytic loop is phosphorylated by phosphoinositide-dependent kinase 1 (PDK-1). Experimental evidence suggests that p70S6K activation requires a phosphoinositide 3-kinase (PI3-K)-dependent signal(s). However, the intermediates between PI3-K and p70S6K remain unclear. Here, we have identified PI3-K-regulated atypical protein kinase C (PKC) isoform PKCzeta as an upstream regulator of p70S6K. In coexpression experiments, we found that a kinase-inactive PKCzeta mutant antagonized activation of p70S6K by epidermal growth factor, PDK-1, and activated Cdc42 and PI3-K. While overexpression of a constitutively active PKCzeta mutant (myristoylated PKCzeta [myr-PKCzeta]) only modestly activated p70S6K, this mutant cooperated with PDK-1 activation of p70S6K. PDK-1-induced activation of a C-terminal truncation mutant of p70S6K was also enhanced by myr-PKCzeta. Moreover, we have found that p70S6K can associate with both PDK-1 and PKCzeta in vivo in a growth factor-independent manner, while PDK-1 and PKCzeta can also associate with each other, suggesting the existence of a multimeric PI3-K signalling complex. This work provides evidence for a link between a phorbol ester-insensitive PKC isoform and p70S6K. The existence of a PI3-K-dependent signalling complex may enable efficient activation of p70S6K in cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10082559      PMCID: PMC84086          DOI: 10.1128/MCB.19.4.2921

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  38 in total

1.  Requirement of protein kinase C zeta for stimulation of protein synthesis by insulin.

Authors:  R Mendez; G Kollmorgen; M F White; R E Rhoads
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  Protein kinase C zeta isoform is critical for mitogenic signal transduction.

Authors:  E Berra; M T Diaz-Meco; I Dominguez; M M Municio; L Sanz; J Lozano; R S Chapkin; J Moscat
Journal:  Cell       Date:  1993-08-13       Impact factor: 41.582

3.  Dual requirement for a newly identified phosphorylation site in p70s6k.

Authors:  B A Moser; P B Dennis; N Pullen; R B Pearson; N A Williamson; R E Wettenhall; S C Kozma; G Thomas
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

4.  Protein kinase C-zeta as a downstream effector of phosphatidylinositol 3-kinase during insulin stimulation in rat adipocytes. Potential role in glucose transport.

Authors:  M L Standaert; L Galloway; P Karnam; G Bandyopadhyay; J Moscat; R V Farese
Journal:  J Biol Chem       Date:  1997-11-28       Impact factor: 5.157

5.  PDGF- and insulin-dependent pp70S6k activation mediated by phosphatidylinositol-3-OH kinase.

Authors:  J Chung; T C Grammer; K P Lemon; A Kazlauskas; J Blenis
Journal:  Nature       Date:  1994-07-07       Impact factor: 49.962

6.  Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation.

Authors:  B Cheatham; C J Vlahos; L Cheatham; L Wang; J Blenis; C R Kahn
Journal:  Mol Cell Biol       Date:  1994-07       Impact factor: 4.272

7.  Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases.

Authors:  J Chung; C J Kuo; G R Crabtree; J Blenis
Journal:  Cell       Date:  1992-06-26       Impact factor: 41.582

8.  Activation of the zeta isozyme of protein kinase C by phosphatidylinositol 3,4,5-trisphosphate.

Authors:  H Nakanishi; K A Brewer; J H Exton
Journal:  J Biol Chem       Date:  1993-01-05       Impact factor: 5.157

9.  An array of insulin-activated, proline-directed serine/threonine protein kinases phosphorylate the p70 S6 kinase.

Authors:  N K Mukhopadhyay; D J Price; J M Kyriakis; S Pelech; J Sanghera; J Avruch
Journal:  J Biol Chem       Date:  1992-02-15       Impact factor: 5.157

10.  Evidence for a role of protein kinase C zeta subspecies in maturation of Xenopus laevis oocytes.

Authors:  I Dominguez; M T Diaz-Meco; M M Municio; E Berra; A García de Herreros; M E Cornet; L Sanz; J Moscat
Journal:  Mol Cell Biol       Date:  1992-09       Impact factor: 4.272

View more
  50 in total

1.  Phosphatidylinositol 3-kinase is required for the expression but not for the induction or the maintenance of long-term potentiation in the hippocampal CA1 region.

Authors:  Pietro Paolo Sanna; Maurizio Cammalleri; Fulvia Berton; Cindy Simpson; Robert Lutjens; Floyd E Bloom; Walter Francesconi
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

2.  Targeting the RAF/MEK/ERK, PI3K/AKT and p53 pathways in hematopoietic drug resistance.

Authors:  James A McCubrey; Linda S Steelman; Richard A Franklin; Steven L Abrams; William H Chappell; Ellis W T Wong; Brian D Lehmann; David M Terrian; Jorg Basecke; Franca Stivala; Massimo Libra; Camilla Evangelisti; Alberto M Martelli
Journal:  Adv Enzyme Regul       Date:  2007-03-26

3.  Decorin-mediated regulation of fibrillin-1 in the kidney involves the insulin-like growth factor-I receptor and Mammalian target of rapamycin.

Authors:  Liliana Schaefer; Wasiliki Tsalastra; Andrea Babelova; Martina Baliova; Jens Minnerup; Lydia Sorokin; Hermann-Josef Gröne; Dieter P Reinhardt; Josef Pfeilschifter; Renato V Iozzo; Roland M Schaefer
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

4.  Atypical protein kinase C activity is required for extracellular matrix degradation and invasion by Src-transformed cells.

Authors:  Elena M Rodriguez; Elizabeth E Dunham; G Steven Martin
Journal:  J Cell Physiol       Date:  2009-10       Impact factor: 6.384

5.  A model of the roles of essential kinases in the induction and expression of late long-term potentiation.

Authors:  Paul Smolen; Douglas A Baxter; John H Byrne
Journal:  Biophys J       Date:  2006-01-13       Impact factor: 4.033

6.  Alteration of Akt activity increases chemotherapeutic drug and hormonal resistance in breast cancer yet confers an achilles heel by sensitization to targeted therapy.

Authors:  James A McCubrey; Melissa L Sokolosky; Brian D Lehmann; Jackson R Taylor; Patrick M Navolanic; William H Chappell; Stephen L Abrams; Kristin M Stadelman; Ellis W T Wong; Negin Misaghian; Stefan Horn; Jörg Bäsecke; Massimo Libra; Franca Stivala; Giovanni Ligresti; Agostino Tafuri; Michele Milella; Marek Zarzycki; Andrzej Dzugaj; Francesca Chiarini; Camilla Evangelisti; Alberto M Martelli; David M Terrian; Richard A Franklin; Linda S Steelman
Journal:  Adv Enzyme Regul       Date:  2008-02-21

7.  Sustained PKCβII activity confers oncogenic properties in a phospholipase D- and mTOR-dependent manner.

Authors:  Mohamad El Osta; Mengling Liu; Mohamad Adada; Can E Senkal; Jolanta Idkowiak-Baldys; Lina M Obeid; Christopher J Clarke; Yusuf A Hannun
Journal:  FASEB J       Date:  2013-10-11       Impact factor: 5.191

8.  Formononetin, a phyto-oestrogen, and its metabolites up-regulate interleukin-4 production in activated T cells via increased AP-1 DNA binding activity.

Authors:  Jin Park; Seung H Kim; Daeho Cho; Tae S Kim
Journal:  Immunology       Date:  2005-09       Impact factor: 7.397

Review 9.  The translation of translational control by FMRP: therapeutic targets for FXS.

Authors:  Jennifer C Darnell; Eric Klann
Journal:  Nat Neurosci       Date:  2013-04-14       Impact factor: 24.884

10.  Activation of aPKC is required for vanadate-induced phosphorylation of protein kinase B (Akt), but not p70S6k in mouse epidermal JB6 cells.

Authors:  Jingxia Li; Sujatha Dokka; Liying Wang; Xianglin Shi; Vincent Castranova; Yan Yan; Max Costa; Chuanshu Huang
Journal:  Mol Cell Biochem       Date:  2004-01       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.